While RGS proteins, including RGS4, have been shown to modulate opioid analgesia (Yoon et al., 2015), reward (Kim et al., 2018), and tolerance pathways (Stewart et al., 2015), RGS role in respiratory depression was yet to be characterized. The gene discussed is PITX2; the disease is respiratory depression.